Edward Joseph Gudaitis

This profile gathers the share dealings of Edward Joseph Gudaitis in Acerus Pharmaceuticals Corporation. We count 18 filings; the first trade dates from 1 May 2018 and the latest from 11 May 2022.

On the market, this insider has only ever bought: 14 purchases, €912k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 1 option exercise. 2022 to date brings 1 purchase and no sales.

A typical purchase (the median) is worth €47k. None of the 14 purchases we analysed coincided with buying by another insider of the same company within 30 days.

The newest entry dates from 11 May 2022: an open-market purchase of €1,654, in Acerus Pharmaceuticals Corporation. Filings reach the SEDI feed a median of 2 days after the trade. The shorter that gap, the sooner other investors can see what insiders have done. This summary is built from SEDI disclosures alone and does not predict where the share price will go.